Back to HALO
RENAISSANCE GROUP LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$34.2M
Q3 2026
Peak value
$35M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $32.4M |
| Q1 2026 | $30.5M |
| Q2 2026 | $35M |
| Q3 2026 | $34.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $34.2M | 309.6K | — | — |
| Q2 2026 | $35M | 447.2K | — | — |
| Q1 2026 | $30.5M | 471.5K | — | — |
| Q4 2025 | $32.4M | 481.2K | — | — |
Other funds holding HALO
$915.4M
$649.5M
$559M
$545.3M
$539.3M
$531.8M